Skip to main content
logo
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,067.40
+17.00 (1.62%)
Aug 25, 2025, 3:30 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2005 - 2019
Pharmaceutical
317.24B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
9.39%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2005 - 2019
United States
144.78B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
3.56%
Log In
Log In
Log In
Log In
Upgrade
Europe
92.36B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
22.12%
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
44.08B
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
8.67%
Log In
Log In
Log In
Log In
Upgrade
India
36.01B
Log In
Log In
Log In
Log In
Upgrade
India Growth
5.86%
Log In
Log In
Log In
Log In
Upgrade